1
|
Ribeiro R, Costa L, Pinto E, Sousa E, Fernandes C. Therapeutic Potential of Marine-Derived Cyclic Peptides as Antiparasitic Agents. Mar Drugs 2023; 21:609. [PMID: 38132930 PMCID: PMC10745025 DOI: 10.3390/md21120609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Revised: 11/18/2023] [Accepted: 11/23/2023] [Indexed: 12/23/2023] Open
Abstract
Parasitic diseases still compromise human health. Some of the currently available therapeutic drugs have limitations considering their adverse effects, questionable efficacy, and long treatment, which have encouraged drug resistance. There is an urgent need to find new, safe, effective, and affordable antiparasitic drugs. Marine-derived cyclic peptides have been increasingly screened as candidates for developing new drugs. Therefore, in this review, a systematic analysis of the scientific literature was performed and 25 marine-derived cyclic peptides with antiparasitic activity (1-25) were found. Antimalarial activity is the most reported (51%), followed by antileishmanial (27%) and antitrypanosomal (20%) activities. Some compounds showed promising antiparasitic activity at the nM scale, being active against various parasites. The mechanisms of action and targets for some of the compounds have been investigated, revealing different strategies against parasites.
Collapse
Affiliation(s)
- Ricardo Ribeiro
- Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; (R.R.); (L.C.); (E.S.)
- Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), Edifício do Terminal de Cruzeiros do Porto de Leixões, Av. General Norton de Matos s/n, 4050-208 Matosinhos, Portugal;
| | - Lia Costa
- Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; (R.R.); (L.C.); (E.S.)
| | - Eugénia Pinto
- Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), Edifício do Terminal de Cruzeiros do Porto de Leixões, Av. General Norton de Matos s/n, 4050-208 Matosinhos, Portugal;
- Laboratório de Microbiologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal
| | - Emília Sousa
- Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; (R.R.); (L.C.); (E.S.)
- Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), Edifício do Terminal de Cruzeiros do Porto de Leixões, Av. General Norton de Matos s/n, 4050-208 Matosinhos, Portugal;
| | - Carla Fernandes
- Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; (R.R.); (L.C.); (E.S.)
- Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), Edifício do Terminal de Cruzeiros do Porto de Leixões, Av. General Norton de Matos s/n, 4050-208 Matosinhos, Portugal;
| |
Collapse
|
2
|
Arndt S, Kohlpaintner PJ, Donsbach K, Waldvogel SR. Synthesis and Applications of Periodate for Fine Chemicals and Important Pharmaceuticals. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.2c00161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Sebastian Arndt
- Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany
| | - Philipp J. Kohlpaintner
- Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany
| | - Kai Donsbach
- Virginia Commonwealth University, College of Engineering, Medicines for All Institute, 601 West Main Street, Richmond, Virginia 23284-3068, United States
| | - Siegfried R. Waldvogel
- Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany
| |
Collapse
|
3
|
Karthikeyan A, Joseph A, Nair BG. Promising bioactive compounds from the marine environment and their potential effects on various diseases. J Genet Eng Biotechnol 2022; 20:14. [PMID: 35080679 PMCID: PMC8790952 DOI: 10.1186/s43141-021-00290-4] [Citation(s) in RCA: 52] [Impact Index Per Article: 26.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2021] [Accepted: 12/17/2021] [Indexed: 12/30/2022]
Abstract
Background The marine environment hosts a wide variety of species that have evolved to live in harsh and challenging conditions. Marine organisms are the focus of interest due to their capacity to produce biotechnologically useful compounds. They are promising biocatalysts for new and sustainable industrial processes because of their resistance to temperature, pH, salt, and contaminants, representing an opportunity for several biotechnological applications. Encouraged by the extensive and richness of the marine environment, marine organisms’ role in developing new therapeutic benefits is heading as an arable field. Main body of the abstract There is currently much interest in biologically active compounds derived from natural resources, especially compounds that can efficiently act on molecular targets, which are involved in various diseases. Studies are focused on bacteria and fungi, isolated from sediments, seawater, fish, algae, and most marine invertebrates such as sponges, mollusks, tunicates, coelenterates, and crustaceans. In addition to marine macro-organisms, such as sponges, algae, or corals, marine bacteria and fungi have been shown to produce novel secondary metabolites (SMs) with specific and intricate chemical structures that may hold the key to the production of novel drugs or leads. The marine environment is known as a rich source of chemical structures with numerous beneficial health effects. Presently, several lines of studies have provided insight into biological activities and neuroprotective effects of marine algae, including antioxidant, anti-neuroinflammatory, cholinesterase inhibitory activity, and neuronal death inhibition. Conclusion The application of marine-derived bioactive compounds has gained importance because of their therapeutic uses in several diseases. Marine natural products (MNPs) display various pharmaceutically significant bioactivities, including antibiotic, antiviral, neurodegenerative, anticancer, or anti-inflammatory properties. The present review focuses on the importance of critical marine bioactive compounds and their role in different diseases and highlights their possible contribution to humanity.
Collapse
Affiliation(s)
- Akash Karthikeyan
- School of Biotechnology, National Institute of Technology Calicut, Calicut, Kerala, India
| | - Abey Joseph
- School of Biotechnology, National Institute of Technology Calicut, Calicut, Kerala, India
| | - Baiju G Nair
- School of Biotechnology, National Institute of Technology Calicut, Calicut, Kerala, India. .,Nanomedical Engineering Laboratory, Riken, Wako, Saitama, Japan.
| |
Collapse
|
4
|
Kazmaier U, Junk L. Recent Developments on the Synthesis and Bioactivity of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides That Demonstrate Anti-Malaria and Anti-Tuberculosis Activity. Mar Drugs 2021; 19:md19080446. [PMID: 34436284 PMCID: PMC8401383 DOI: 10.3390/md19080446] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2021] [Revised: 07/29/2021] [Accepted: 07/30/2021] [Indexed: 01/08/2023] Open
Abstract
Ilamycins/rufomycins and cyclomarins are marine cycloheptapeptides containing unusual amino acids. Produced by Streptomyces sp., these compounds show potent activity against a range of mycobacteria, including multidrug-resistant strains of Mycobacterium tuberculosis. The cyclomarins are also very potent inhibitors of Plasmodium falciparum. Biosynthetically the cyclopeptides are obtained via a heptamodular nonribosomal peptide synthetase (NRPS) that directly incorporates some of the nonproteinogenic amino acids. A wide range of derivatives can be obtained by fermentation, while bioengineering also allows the mutasynthesis of derivatives, especially cyclomarins. Other derivatives are accessible by semisynthesis or total syntheses, reported for both natural product classes. The anti-tuberculosis (anti-TB) activity results from the binding of the peptides to the N-terminal domain (NTD) of the bacterial protease-associated unfoldase ClpC1, causing cell death by the uncontrolled proteolytic activity of this enzyme. Diadenosine triphosphate hydrolase (PfAp3Aase) was found to be the active target of the cyclomarins in Plasmodia. SAR studies with natural and synthetic derivatives on ilamycins/rufomycins and cyclomarins indicate which parts of the molecules can be simplified or otherwise modified without losing activity for either target. This review examines all aspects of the research conducted in the syntheses of these interesting cyclopeptides.
Collapse
Affiliation(s)
- Uli Kazmaier
- Organic Chemistry, Saarland University, Campus Building C4.2, 66123 Saarbrücken, Germany;
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)—Helmholtz Centre for Infection Research (HZI), Campus Building E8 1, 66123 Saarbrücken, Germany
- Correspondence: ; Tel.: +49-681-302-3409
| | - Lukas Junk
- Organic Chemistry, Saarland University, Campus Building C4.2, 66123 Saarbrücken, Germany;
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)—Helmholtz Centre for Infection Research (HZI), Campus Building E8 1, 66123 Saarbrücken, Germany
| |
Collapse
|
5
|
Yin X, Li W, Yu B. Synthesis of Pashinintide A, a Natural Cyclic Hexapeptide Supposedly Capable of Forming a Complex with Sucrose. ASIAN J ORG CHEM 2020. [DOI: 10.1002/ajoc.201900663] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Xuejian Yin
- State Key Laboratory of Bioorganic and Natural Products Chemistry Shanghai Institute of Organic ChemistryUniversity of Chinese Academy of Sciences Chinese Academy of Sciences 345 Lingling Road Shanghai 200032 China
| | - Wei Li
- Department of Medicinal ChemistryChina Pharmaceutical University 639 Longmian Avenue, Nanjing Jiangsu 211198 China
| | - Biao Yu
- State Key Laboratory of Bioorganic and Natural Products Chemistry Shanghai Institute of Organic ChemistryUniversity of Chinese Academy of Sciences Chinese Academy of Sciences 345 Lingling Road Shanghai 200032 China
| |
Collapse
|
6
|
Kiefer A, Bader CD, Held J, Esser A, Rybniker J, Empting M, Müller R, Kazmaier U. Synthesis of New Cyclomarin Derivatives and Their Biological Evaluation towards
Mycobacterium Tuberculosis
and
Plasmodium Falciparum. Chemistry 2019; 25:8894-8902. [DOI: 10.1002/chem.201901640] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2019] [Indexed: 01/03/2023]
Affiliation(s)
- Alexander Kiefer
- Organic ChemistrySaarland University Campus C4.2 66123 Saarbrücken Germany
| | - Chantal D. Bader
- Department Microbial Natural Products (MINS)Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)–Helmholtz Centre for Infection Research (HZI) Campus E8.1 66123 Saarbrücken Germany
| | - Jana Held
- Department of Tropical MedicineUniversity of Tübingen Wilhelmstraße 27 72074 Tübingen Germany
| | - Anna Esser
- Center for Molecular Medicine CologneUniversity of Cologne Robert Koch Str. 21 50931 Cologne Germany
| | - Jan Rybniker
- Department I of Internal MedicineUniversity of Cologne 50937 Cologne (Germany) and German Center for Infection Research (DZIF), Partner Site Bonn-Cologne Germany
| | - Martin Empting
- Department of Drug Design and Optimization (DDOP)Helmholtz-Institute for Pharmaceutical Research Saarland, (HIPS)–Helmholtz Centre for Infection Research (HZI) Campus E8.1 66123 Saarbrücken Germany
| | - Rolf Müller
- Department Microbial Natural Products (MINS)Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)–Helmholtz Centre for Infection Research (HZI) Campus E8.1 66123 Saarbrücken Germany
- Department of PharmacySaarland University Campus E8.1 66123 Saarbrücken Germany
| | - Uli Kazmaier
- Organic ChemistrySaarland University Campus C4.2 66123 Saarbrücken Germany
| |
Collapse
|
7
|
Pandey A. Pharmacological Potential of Marine Microbes. ENVIRONMENTAL CHEMISTRY FOR A SUSTAINABLE WORLD 2019. [DOI: 10.1007/978-3-030-04675-0_1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
8
|
Kiefer A, Kazmaier U. Synthesis of modified β-methoxyphenylalanines via diazonium chemistry and their incorporation in desoxycyclomarin analogues. Org Biomol Chem 2019; 17:88-102. [PMID: 30520486 DOI: 10.1039/c8ob02777c] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Chloramphenicol base is converted into substituted syn-β-methoxyphenylalanins, building blocks of modified cyclomarins.
Collapse
Affiliation(s)
- Alexander Kiefer
- Institute of Organic Chemistry
- Saarland University
- 66041 Saarbrücken
- Germany
| | - Uli Kazmaier
- Institute of Organic Chemistry
- Saarland University
- 66041 Saarbrücken
- Germany
| |
Collapse
|
9
|
Antiinflammatory peptides: current knowledge and promising prospects. Inflamm Res 2018; 68:125-145. [PMID: 30560372 DOI: 10.1007/s00011-018-1208-x] [Citation(s) in RCA: 41] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2018] [Revised: 10/19/2018] [Accepted: 12/12/2018] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Inflammation is part of the regular host reaction to injury or infection caused by toxic factors, pathogens, damaged cells, irritants, and allergens. Antiinflammatory peptides (AIPs) are present in all living organisms, and many peptides from herbal, mammalian, bacterial, and marine origins have been shown to have antimicrobial and/or antiinflammatory properties. METHODS In this study, we investigated the effects of antiinflammatory peptides on inflammation, and highlighted the underlying mechanisms responsible for these effects. RESULTS In multicellular organisms, including humans, AIPs constitute an essential part of their immune system. In addition, numerous natural and synthetic AIPs are effective immunomodulators and can interfere with signal transduction pathways involved in inflammatory cytokine expression. Among them, some peptides such as antiflammin, N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP), and those derived from velvet antler proteins, bee venom, horse fly salivary gland, and bovine β-casein have received considerable attention over the past few years. CONCLUSION This article presents an overview on the major properties and mechanisms of action associated with AIPs as immunomodulatory, chemotactic, antioxidant, and antimicrobial agents. In addition, the results of various studies dealing with effects of AIPs on numerous classical models of inflammation are reviewed and discussed.
Collapse
|
10
|
Choules MP, Klein LL, Lankin DC, McAlpine JB, Cho SH, Cheng J, Lee H, Suh JW, Jaki BU, Franzblau SG, Pauli GF. Residual Complexity Does Impact Organic Chemistry and Drug Discovery: The Case of Rufomyazine and Rufomycin. J Org Chem 2018; 83:6664-6672. [PMID: 29792329 PMCID: PMC6006449 DOI: 10.1021/acs.joc.8b00988] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
![]()
Residual complexity (RC) involves
the impact of subtle but critical structural and biological features on drug lead validation, including unexplained effects related to unidentified impurities. RC commonly plagues drug discovery efforts due to the inherent imperfections
of chromatographic separation methods. The new diketopiperazine, rufomyazine
(6), and the previously known antibiotic, rufomycin (7), represent a prototypical case of RC that (almost) resulted
in the misassignment of biological activity. The case exemplifies
that impurities well below the natural abundance of 13C
(1.1%) can be highly relevant and calls for advanced analytical characterization
of drug leads with extended molar dynamic ranges of >1:1,000 using
qNMR and LC-MS. Isolated from an actinomycete strain, 6 was originally found to be active against Mycobacterium
tuberculosis with a minimum inhibitory concentration (MIC)
of 2 μg/mL and high selectivity. As a part of lead validation,
the dipeptide was synthesized and surprisingly found to be inactive.
The initially observed activity was eventually attributed to
a very minor contamination (0.24% [m/m]) with a highly active cyclic
peptide (MIC ∼ 0.02 μM), subsequently identified as an
analogue of 7. This study illustrates the serious implications
RC can exert on organic chemistry and drug discovery, and what efforts
are vital to improve lead validation and efficiency, especially in
NP-related drug discovery programs.
Collapse
|
11
|
Katsuta R, Toyoda M, Yajima A, Ishigami K, Nukada T. Synthesis and stereochemistry of JBIR-81, a peptide enamide derived from aspergilli. Tetrahedron Lett 2018. [DOI: 10.1016/j.tetlet.2018.01.080] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
12
|
|
13
|
Barbie P, Kazmaier U. Total Synthesis of Cyclomarin A, a Marine Cycloheptapeptide with Anti-Tuberculosis and Anti-Malaria Activity. Org Lett 2015; 18:204-7. [DOI: 10.1021/acs.orglett.5b03292] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Philipp Barbie
- Organic Chemistry I, Saarland University, Campus Building C4.2, D-66123 Saarbrücken, Germany
| | - Uli Kazmaier
- Organic Chemistry I, Saarland University, Campus Building C4.2, D-66123 Saarbrücken, Germany
| |
Collapse
|
14
|
Barbie P, Kazmaier U. Synthesis of fully protected, reverse N-prenylated (2S,3R)-3-hydroxytryptophan, a unique building block of the cyclomarins. Org Biomol Chem 2015; 13:9267-75. [DOI: 10.1039/c5ob01438g] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The rather exotic amino acid of the cyclomarins, is obtained in enantio- and diastereomerically pure and fully protected form.
Collapse
Affiliation(s)
- Philipp Barbie
- Institute of Organic Chemistry
- Saarland University
- 66041 Saarbrücken
- Germany
| | - Uli Kazmaier
- Institute of Organic Chemistry
- Saarland University
- 66041 Saarbrücken
- Germany
| |
Collapse
|
15
|
D’Orazio N, Gammone MA, Gemello E, De Girolamo M, Cusenza S, Riccioni G. Marine bioactives: pharmacological properties and potential applications against inflammatory diseases. Mar Drugs 2012; 10:812-833. [PMID: 22690145 PMCID: PMC3366677 DOI: 10.3390/md10040812] [Citation(s) in RCA: 87] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2012] [Revised: 03/15/2012] [Accepted: 03/23/2012] [Indexed: 12/12/2022] Open
Abstract
Inflammation is a hot topic in medical research, because it plays a key role in inflammatory diseases: rheumatoid arthritis (RA) and other forms of arthritis, diabetes, heart diseases, irritable bowel syndrome, Alzheimer's disease, Parkinson's disease, allergies, asthma, even cancer and many others. Over the past few decades, it was realized that the process of inflammation is virtually the same in different disorders, and a better understanding of inflammation may lead to better treatments for numerous diseases. Inflammation is the activation of the immune system in response to infection, irritation, or injury, with an influx of white blood cells, redness, heat, swelling, pain, and dysfunction of the organs involved. Although the pathophysiological basis of these conditions is not yet fully understood, reactive oxygen species (ROS) have often been implicated in their pathogenesis. In fact, in inflammatory diseases the antioxidant defense system is compromised, as evidenced by increased markers of oxidative stress, and decreased levels of protective antioxidant enzymes in patients with rheumatoid arthritis (RA). An enriched diet containing antioxidants, such as vitamin E, vitamin C, β-carotene and phenolic substances, has been suggested to improve symptoms by reducing disease-related oxidative stress. In this respect, the marine world represents a largely untapped reserve of bioactive ingredients, and considerable potential exists for exploitation of these bioactives as functional food ingredients. Substances such as n-3 oils, carotenoids, vitamins, minerals and peptides provide a myriad of health benefits, including reduction of cardiovascular diseases, anticarcinogenic and anti-inflammatory activities. New marine bioactives are recently gaining attention, since they could be helpful in combating chronic inflammatory degenerative conditions. The aim of this review is to examine the published studies concerning the potential pharmacological properties and application of many marine bioactives against inflammatory diseases.
Collapse
Affiliation(s)
- Nicolantonio D’Orazio
- Human Nutrition, Department of Biomedical Science, via Dei Vestini, University G. D’Annunzio, Chieti, 66013, Italy
| | - Maria Alessandra Gammone
- Human Nutrition, Department of Biomedical Science, via Dei Vestini, University G. D’Annunzio, Chieti, 66013, Italy
| | - Eugenio Gemello
- Human Nutrition, Department of Biomedical Science, via Dei Vestini, University G. D’Annunzio, Chieti, 66013, Italy
| | - Massimo De Girolamo
- Human Nutrition, Department of Biomedical Science, via Dei Vestini, University G. D’Annunzio, Chieti, 66013, Italy
| | - Salvatore Cusenza
- Human Nutrition, Department of Biomedical Science, via Dei Vestini, University G. D’Annunzio, Chieti, 66013, Italy
| | - Graziano Riccioni
- Human Nutrition, Department of Biomedical Science, via Dei Vestini, University G. D’Annunzio, Chieti, 66013, Italy
- Cardiology Unit, San Camillo De Lellis Hospital, Manfredonia, FG, Italy
| |
Collapse
|
16
|
Intaraudom C, Rachtawee P, Suvannakad R, Pittayakhajonwut P. Antimalarial and antituberculosis substances from Streptomyces sp. BCC26924. Tetrahedron 2011. [DOI: 10.1016/j.tet.2011.07.053] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
17
|
Synthesis of the ‘southern’ tripeptide of Cyclomarins A and C having novel anti-tuberculocidal mode of action. ACTA ACUST UNITED AC 2011. [DOI: 10.1016/j.tetasy.2011.08.026] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
18
|
Tellam JP, Carbery DR. Development of the Ireland−Claisen Rearrangement of Alkoxy- and Aryloxy-Substituted Allyl Glycinates. J Org Chem 2010; 75:7809-21. [PMID: 20958078 DOI: 10.1021/jo1017124] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- James P. Tellam
- Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom
| | - David R. Carbery
- Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom
| |
Collapse
|
19
|
Mikami Y, Kumamoto T, Koshino H, Watanabe D, Matsumoto Y, Aoyama K, Harada KI, Ishikawa T. M10709, a New Cyclic Peptide Antibiotic from Clinically Isolated Streptomyces sp. HETEROCYCLES 2010. [DOI: 10.3987/com-09-s(s)11] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
20
|
Genovese S, Curini M, Epifano F. Chemistry and biological activity of azoprenylated secondary metabolites. PHYTOCHEMISTRY 2009; 70:1082-1091. [PMID: 19660768 DOI: 10.1016/j.phytochem.2009.06.016] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/12/2009] [Revised: 06/15/2009] [Accepted: 06/16/2009] [Indexed: 05/28/2023]
Abstract
N-Prenyl secondary metabolites (isopentenylazo-, geranylazo-, farnesylazo- and their biosynthetic derivatives) represent a family of extremely rare natural products. Only in recent years have these alkaloids been recognized as interesting and valuable biologically active secondary metabolites. To date about 35 alkaloids have been isolated from plants mainly belonging to the Rutaceae family, and from fungi, bacteria, and/or obtained by chemical synthesis. These metabolites comprise anthranilic acid derivatives, diazepinones, and indole, and xanthine alkaloids. Many of the isolated prenylazo secondary metabolites and their semisynthetic derivatives are shown to exert valuable in vitro and in vivo anti-cancer, anti-inflammatory, anti-bacterial, anti-viral, and anti-fungal effects. The aim of this comprehensive review is to examine the different types of prenylazo natural products from a chemical, phytochemical and biological perspective.
Collapse
Affiliation(s)
- Salvatore Genovese
- Dipartimento di Scienze del Farmaco, Università "G. D'Annunzio" di Chieti-Pescara, Via dei Vestini 31, 66100 Chieti Scalo (CH), Italy.
| | - Massimo Curini
- Dipartimento di Chimica e Tecnologia del Farmaco, Sezione di Chimica Organica, Università degli Studi di Perugia, Via del Liceo, 06123 Perugia, Italy
| | - Francesco Epifano
- Dipartimento di Scienze del Farmaco, Università "G. D'Annunzio" di Chieti-Pescara, Via dei Vestini 31, 66100 Chieti Scalo (CH), Italy
| |
Collapse
|
21
|
Abstract
This review covers the literature published in 2005 for marine natural products, with 704 citations (493 for the period January to December 2005) referring to compounds isolated from marine microorganisms and phytoplankton, green algae, brown algae, red algae, sponges, coelenterates, bryozoans, molluscs, tunicates and echinoderms. The emphasis is on new compounds (812 for 2005), together with their relevant biological activities, source organisms and country of origin. Biosynthetic studies, first syntheses, and syntheses that lead to the revision of structures or stereochemistries, have been included.
Collapse
Affiliation(s)
- John W Blunt
- Department of Chemistry, University of Canterbury, Christchurch, New Zealand.
| | | | | | | | | | | |
Collapse
|
22
|
Hamada Y, Shioiri T. Recent progress of the synthetic studies of biologically active marine cyclic peptides and depsipeptides. Chem Rev 2006; 105:4441-82. [PMID: 16351050 DOI: 10.1021/cr0406312] [Citation(s) in RCA: 218] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Yasumasa Hamada
- Graduate School of Pharmaceutical Sciences, Chiba University, Yayoi-cho, Inage-ku, Japan.
| | | |
Collapse
|
23
|
A stereoselective synthesis of (2S,3R)-β-methoxyphenylalanine: a component of cyclomarin A. ACTA ACUST UNITED AC 2005. [DOI: 10.1016/j.tetasy.2005.10.029] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|